We aspire to become a leading biopharmaceutical company recognized globally for its innovative treatments that address unmet medical needs, particularly in the central nervous system (CNS) and immune-related diseases. The company aims to be a key player in transforming patient outcomes by providing advanced, effective therapies for conditions with limited or no treatment options.